Moreover, NT-PGC-1α−/− female mice were protected from HFD-induced hepatic steatosis as evidenced by a decrease in weight, lipid droplet accumulation, and TG content in the liver (Fig. 4A–C). Here, PPARGC1A is linked to fatty liver disease.